IRIS Accounts Production v23.3.1.45 04163487 Board of Directors 1.5.22 30.4.23 30.4.23 false true false false true false Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh041634872022-04-30041634872023-04-30041634872022-05-012023-04-30041634872021-04-30041634872021-05-012022-04-30041634872022-04-3004163487ns10:Originalns15:EnglandWales2022-05-012023-04-3004163487ns14:PoundSterlingns10:Original2022-05-012023-04-3004163487ns10:Originalns10:Director12022-05-012023-04-3004163487ns10:Original2022-05-012023-04-3004163487ns10:Original2023-04-3004163487ns10:Originalns10:PrivateLimitedCompanyLtd2022-05-012023-04-3004163487ns10:Originalns10:SmallEntities2022-05-012023-04-3004163487ns10:Originalns10:AuditExempt-NoAccountantsReport2022-05-012023-04-3004163487ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-05-012023-04-3004163487ns10:SmallCompaniesRegimeForAccountsns10:Original2022-05-012023-04-3004163487ns10:Originalns10:FullAccounts2022-05-012023-04-3004163487ns10:Originalns10:OrdinaryShareClass12022-05-012023-04-3004163487ns10:Originalns10:Director22022-05-012023-04-3004163487ns10:CompanySecretary1ns10:Original2022-05-012023-04-3004163487ns10:Originalns10:RegisteredOffice2022-05-012023-04-3004163487ns10:Original2022-04-3004163487ns10:Originalns5:CurrentFinancialInstruments2023-04-3004163487ns10:Originalns5:CurrentFinancialInstruments2022-04-3004163487ns5:ShareCapitalns10:Original2023-04-3004163487ns5:ShareCapitalns10:Original2022-04-3004163487ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-04-3004163487ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-04-3004163487ns10:Originalns5:PlantMachinery2022-05-012023-04-3004163487ns10:Original2021-05-012022-04-3004163487ns10:Originalns5:LandBuildings2022-04-3004163487ns10:Originalns5:PlantMachinery2022-04-3004163487ns10:Original2022-04-3004163487ns10:Originalns5:LandBuildings2022-05-012023-04-3004163487ns10:Originalns5:LandBuildings2023-04-3004163487ns10:Originalns5:PlantMachinery2023-04-3004163487ns10:Originalns5:LandBuildings2022-04-3004163487ns10:Originalns5:PlantMachinery2022-04-3004163487ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-3004163487ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-04-3004163487ns10:Originalns10:OrdinaryShareClass12023-04-3004163487ns10:Original12022-05-012023-04-30
REGISTERED NUMBER: 04163487 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH APRIL 2023

FOR

HODGSON PHARMACY LIMITED

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH APRIL 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


HODGSON PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30TH APRIL 2023







DIRECTORS: Mr D C Patel
Mr A D Patel



SECRETARY: Mr D C Patel



REGISTERED OFFICE: 59 Station Road
Longfield
Kent
DA3 7QA



REGISTERED NUMBER: 04163487 (England and Wales)



BANKERS: National Westminster Bank plc
12 High Street
Dartford
Kent
DA1 1DD

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

BALANCE SHEET
30TH APRIL 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 117,729 120,705

CURRENT ASSETS
Stocks 79,577 73,109
Debtors 5 43,780 37,401
Cash at bank and in hand 227,454 275,733
350,811 386,243
CREDITORS
Amounts falling due within one year 6 234,600 257,699
NET CURRENT ASSETS 116,211 128,544
TOTAL ASSETS LESS CURRENT
LIABILITIES

233,940

249,249

PROVISIONS FOR LIABILITIES 47,000 47,000
NET ASSETS 186,940 202,249

CAPITAL AND RESERVES
Called up share capital 7 20,000 20,000
Retained earnings 166,940 182,249
SHAREHOLDERS' FUNDS 186,940 202,249

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th April 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th April 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20th November 2023 and were signed on its behalf by:





Mr D C Patel - Director


HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH APRIL 2023


1. STATUTORY INFORMATION

Hodgson Pharmacy Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 04163487 and registered office address is 59 Station Road, Longfield, Kent, DA3 7QA.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 15% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2022 - 9 ) .

4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1st May 2022 29,286 461,373 490,659
Additions - 23,690 23,690
At 30th April 2023 29,286 485,063 514,349
DEPRECIATION
At 1st May 2022 22,615 347,339 369,954
Charge for year 1,001 25,665 26,666
At 30th April 2023 23,616 373,004 396,620
NET BOOK VALUE
At 30th April 2023 5,670 112,059 117,729
At 30th April 2022 6,671 114,034 120,705

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30TH APRIL 2023


5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 8,559 15,734
Other debtors 35,221 21,667
43,780 37,401

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 168,350 192,403
Taxation and social security 2,338 3,950
Other creditors 63,912 61,346
234,600 257,699

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
20,000 Ordinary shares £1 20,000 20,000

8. RELATED PARTY DISCLOSURES

The company paid £12,000 (2021: £12,000) as rent to Mr D.C. Patel. An amount of £24,318 (2022: £24,541) was due to Mr D C Patel at the year end.

9. POST BALANCE SHEET EVENTS

The company has exchanged contracts after the year end to acquire a pharmacy business.

10. ULTIMATE CONTROLLING PARTY

The company was under the control of the director and majority shareholder, Mr D.C. Patel throughout the current year and previous period.